Quarterly report [Sections 13 or 15(d)]

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Mar. 31, 2026
Mar. 31, 2025
Income Statement [Abstract]        
Revenue $ 1,133,502 $ 955,703 $ 2,386,041 $ 1,923,027
Cost of Revenue 227,861 180,651 402,824 395,589
Gross Profit 905,641 775,052 1,983,217 1,527,438
Operating Expenses:        
Selling expenses 60,782 64,901 86,709 117,990
Administrative expenses 784,955 735,902 1,646,422 1,483,636
Depreciation and amortization expense 5,670 5,722 11,063 11,205
Research and development 2,000 4,000 4,000 6,000
Total Operating Expenses 853,407 810,525 1,748,194 1,618,831
Interest income/expense, net 11,537 7,381 23,554 14,176
Total Other Income/(Expenses) 11,537 7,381 23,554 14,176
Income (Loss) before income taxes 63,771 (28,092) 258,577 (77,217)
Provision for income taxes from continuing operations
Net income (loss) 63,771 (28,092) 258,577 (77,217)
Preferred stock dividends Series A Preferred (10,119) (10,118) (20,462) (20,461)
Net income (loss) attributable to common stockholders $ 53,652 $ (38,210) $ 238,115 $ (97,678)
Net income (loss) per common share - basic $ 0.00 $ (0.00) $ 0.00 $ (0.00)
Net income (loss) per common share - diluted $ 0.00 $ (0.00) $ 0.00 $ (0.00)
Weighted Average of number of shares outstanding -  basic 229,238,517 229,160,695 229,238,517 229,160,695
Weighted Average of number of shares outstanding -  diluted 599,560,152 229,160,695 599,560,152 229,160,695